PERSANTINE Drug Patent Profile
✉ Email this page to a colleague
When do Persantine patents expire, and when can generic versions of Persantine launch?
Persantine is a drug marketed by Boehringer Ingelheim and is included in one NDA.
The generic ingredient in PERSANTINE is dipyridamole. There are eighteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the dipyridamole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Persantine
A generic version of PERSANTINE was approved as dipyridamole by BARR on October 3rd, 1990.
Summary for PERSANTINE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 148 |
Clinical Trials: | 9 |
Patent Applications: | 4,220 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in PERSANTINE? | PERSANTINE excipients list |
DailyMed Link: | PERSANTINE at DailyMed |
Recent Clinical Trials for PERSANTINE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Guo-Qing Jiang | N/A |
Children's Hospital of Fudan University | Phase 1/Phase 2 |
Shanghai Children's Hospital | Phase 1/Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for PERSANTINE
US Patents and Regulatory Information for PERSANTINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Boehringer Ingelheim | PERSANTINE | dipyridamole | TABLET;ORAL | 012836-003 | Dec 22, 1986 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Boehringer Ingelheim | PERSANTINE | dipyridamole | TABLET;ORAL | 012836-004 | Feb 6, 1987 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Boehringer Ingelheim | PERSANTINE | dipyridamole | TABLET;ORAL | 012836-005 | Feb 6, 1987 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |